India Expected To Get Next Set Of U.S. FDA Permanent Staff
This article was originally published in PharmAsia News
Executive Summary
India is likely to be next on the list of U.S. FDA plans to station inspectors in other countries as a follow-up to a similar step earlier in March in China. The agency said it would have eight full-time positions in China to monitor medicines intended for export to the United States, and plans to locate personnel in Europe, India, South America and West Asia. India is expected to be next to receive U.S. FDA inspectors since it has the largest number of FDA-approved drug plants outside the United States. (Click here for more